You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
McKinsey
AstraZeneca
Johnson and Johnson
Baxter

Last Updated: October 27, 2020

DrugPatentWatch Database Preview

Details for Patent: 6,335,031

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,335,031
Title: TTS containing an antioxidant
Abstract:Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
Inventor(s): Asmussen; Bodo (Bendorf-Sayn, DE), Horstmann; Michael (Neuwied, DE), Kopke; Kai (Triengen, CH), Tiemessen; Henricus L. G. M. (Weil-Haltingen, DE), Dinh; Steven Minh (Briarcliff Manor, NY), Gargiulo; Paul M. (New York, NY)
Assignee: Novartis AG (Basel, CH) LTS Lohmann Therapie-Systeme GmbH Co. KG (Neuwied, DE)
Application Number:09/291,498
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,335,031
Patent Claim Types:
see list of patent claims
Composition; Device; Use;

Drugs Protected by US Patent 6,335,031

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,335,031

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany9800526Jan 12, 1998

International Family Members for US Patent 6,335,031

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 223711   Start Trial
Australia 2278599   Start Trial
Australia 745661   Start Trial
Brazil 9906920   Start Trial
Canada 2315784   Start Trial
China 1129427   Start Trial
China 1288375   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
AstraZeneca
Baxter
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.